Three tests are now FDA-approved for triaging pelvic masses in asymptomatic women.
Andrew John Li, MD
Letters discuss the myriad of issues affecting the practice of specialties. Joshua A. Copel responds.
Letters discuss global endometrial ablations, intrauterine scarring, and disagreements over cancer biomarkers. Steven R. Goldstein and Andrew John Li respond.